Volume 5 ; Issue 2 ; in Month : Jul-Dec (2022) Article No : 126
Valerio Massimo Magro

Abstract

The irritating bowel syndrome is a very common condition in the elderly, and it can also be extremely disabling being able to go to undermine the patient's independence. We wanted to conduct a study on the Territory, wanting to test a molecule recently approved for the treatment of variant with constipation-predominant irritable bowel syndrome, testing the treatment in a cohort of elderly subjects and comparing the results with those of other existing therapies. Here we expose the results of our experience.

Full Text Attachment

Views : 310      Downloads : 1

RSS